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Abstract Background: Clostridium difficile infection is a serious hospital-acquired infection,
causing negative outcomes for those who are afflicted by it. Hospital length of stay is known to
be a risk factor for transmission and significant reductions in infection numbers can be realised
if transmission is reduced.
Methods: A Markov model was constructed to compare the impact that five alternative health-
care scenarios had on total C. difficile infections, QALYs gained and total number of patients
requiring treatment in ICU. A previously published stochastic transmission model for C. difficile
informed scenario effectiveness, while other parameters were estimated from published liter-
ature, administrative datasets and expert opinion.
Results: Reducing inpatient LOS disrupts transmission of C. difficile and results in a large
reduction of total infections. In turn, an increase in QALYs is expected when the number of in-
fections is reduced. A reduction in infections reduces the number of ICU admissions, which is
likely to have a large economic benefit in the Australian setting. Coupling a reduction in overall
inpatient LOS with a ‘traditional’ infection control intervention, such as hand hygiene or anti-
microbial stewardship, improves results further than reducing LOS on its own.
Conclusion: Implementing a LOS-focused intervention would be a practical challenge, espe-
cially for clinicians who already juggle high demand. However, it is not unattainable with
the right local endorsement and could have significant benefits for health services.
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Highlights
 Reducing overall LOS has positive impacts on Clostridium difficile-related health outcomes.
 A reduction in C. difficile infections is expected when LOS is reduced.
 Economic benefits are likely when infections are reduced and QALYs are gained.
Introduction
Patient length of stay (LOS) has long been linked with
influencing transmission of Clostridium difficile infection
(CDI) [1,2]. It has previously been shown that the longer a
patient stays in hospital, the greater their chances of
infection, as risk rises cumulatively for each day in hospital
[3e5]. It is also clear that there are economic conse-
quences when there is an increase in C. difficile infections
[6,7]. Analysis of prior occupant’s CDI status has likewise
shown a significant risk for acquisition when CDI was pre-
viously detected [8].
Despite a good understanding that in the last decade
hospital LOS has steadily reduced in the majority of
Australian hospitals, there has not yet been a quantification
of the impact that a reduction in LOS could have on C.
difficile outcomes in the Australian setting. This study
aimed to determine the extent to which C. difficile-related
health outcomes could be improved by better management
of inpatient LOS. Despite LOS-reduction not being cat-
egorised as a ‘traditional’ infection control measure, a
reduction in LOS is a plausible byproduct of a system-wide
improvement in patient management.
Methods
A Markov model was constructed to compare five different
healthcare scenarios and measure the influence that these
scenarios had on the following health outcomes: total
number of C. difficile infections avoided, number of
quality-adjusted life years (QALYs) gained, and number of
patients requiring admission to the intensive care unit due
to suffering a severe C. difficile infection. The structure of
the model has been described in detail elsewhere [7] and a
pictorial representation is in Appendix 1. The clinical
effectiveness of each scenario was estimated from the re-
sults of a previously published, stochastic transmission
model which assessed the increase or decrease in C. diffi-
cile transmission as a result of that scenario [9]. All sce-
narios were compared to ‘standard care’, which was
assumed to be: a current antimicrobial stewardship pro-
gramme or antimicrobial restriction policy (AMS), a hand
hygiene and environmental cleaning programme for the
whole hospital, and the capacity to undertake fecal
microbiota transplant (FMT). Rates consistent with those
previously published were used [9]: the baseline level of
antimicrobial exposure in a hospital at any given time was
assumed to be 50% of inpatients [10,11]; the average time
for gut flora to be properly restored was 90 days post-
infection [12]; and the average length of stay for all hos-
pitalised patients was assumed to be 5.8 days [13]. The
scenarios considered are described in Table 1.
The scenarios and their chosen level of efficacy were
informed by a panel of experienced clinicians and infection
control practitioners. The scenarios chosen for this study
were deemed to be realistically achievable in the Austra-
lian setting. However, due to the flexibility of the mathe-
matical model that informed the efficacy of each scenario,
the chosen level for analysis can be manipulated according
to local requirements, if desired. For example, if there is
local evidence suggesting a smaller reduction in LOS is more
plausible for their setting, analysts in that setting can easily
alter the efficacy parameters in the model, to produce a
more locally-relevant result. The research team is happy to
share the model, which is built in Microsoft Excel, on a
suitable open access platform for others to evaluate
different strategy efficacy levels that are not explicitly
shown in these results.
Table 1 Scenarios included in the analysis.
Scenario Description
LOS 1 A reduction in the average LOS by 1 day (from 5.8 days to 4.8 days)
LOS 2 A reduction in the average LOS by 2 days (from 5.8 days to 3.8 days)
LOS & AMS 1 LOS & AMS bundle where the average LOS is reduced by 1 day and the number of people exposed to
antibiotics is reduced from 50% to 40%.
LOS & AMS 2 LOS & AMS bundle where the average LOS is reduced by 2 days and the number of people exposed to
antibiotics is reduced from 50% to 40%.
LOS & HYG LOS & hygiene improvement bundle where the average LOS is reduced by 1 day and the transmission
rate of infection is halved by the effectiveness of a hygiene improvement program
88 D.C. Brain et al.
Data sources, assumptions and related limitations
The best available evidence was sought, but as is typical for
modelling studies, it was obtained from a range of sources,
both within Australia and from published work outside the
Australian setting. Table 2 shows data sources for each
input variable used in the Markov model. Health utility
weights were assigned to all health states in the model,
with the majority of estimates derived from published
studies. Expert opinion was used for health states that
could not be informed from the literature. This approach is
appropriate given the prohibitive cost and practical
Table 2 Input variables for the Markov model.
Variable Fixed value Range Distribution Reference
Health utilities (Daily)
At-risk 0.92 0.84e0.96 Uniform
Non-severe 0.82 0.72e0.93 Uniform [14]
Severe 0.71 0.50e0.72 Uniform [14]
Discharged vulnerable 1 0.85 0.75e0.90 Uniform [15]
Recurrent infection 0.61 0.50e0.72 Uniform [15]
Discharged vulnerable 2 0.80 0.70e0.85 Uniform [15]
Discharged healthy 0.88 0.84e0.92 Uniform [16]
Costs ($AUD) ($AUD)
Diagnosis (non-severe) $58.48 $52.63e$64.33 Uniform [17]
Diagnosis (severe) $29.24 $26.32e$32.16 Uniform [17]
Diagnosis (recurrent inf) $16.08 $14.48e$17.69 Uniform [17]
Hospital (non-severe) $800 $720e$880 Uniform [18]
Hospital (severe) $3000 $2700e$3300 Uniform [18]
Hospital (recurrent inf) $1900 $1710e$2090 Uniform [18]
Treatment (non-severe) $3.71 $3.34e$4.08 Uniform [19]
Treatment (severe) $47.43 $42.69e$52.17 Uniform [19]
Treatment (recurrent inf) $99.69 $89.72e$109.66 Uniform [19]
Transition probabilities (alpha; beta)
At-risk to:
Remain at-risk 0.273 (236461; 629636) Beta [20]
Non-severe 0.0001 (93; 866004) Beta [20]
Severe 4.61E-06 (4; 866093) Beta [20]
Discharged healthy 0.725 (628408; 237689) Beta [20]
Dead 0.001 (1131; 864966) Beta [21]
Non-severe infection to:
Remain non-severe 0.752 (70; 23) Beta [20]
Dead 0.000 (0.1; 93.1) Beta [20]
Discharged vulnerable 1 0.247 (23; 70) Beta [20]
Severe infection to:
Remain severe 0.75 (3; 1) Beta [20]
Dead 0.000 (0.1; 4.1) Beta [20]
Discharged vulnerable 1 0.25 (1; 3) Beta [20]
Discharged vulnerable 1 to:
Remain discharged vulnerable 1 0.829 (85; 632) Beta [20]
Censored 0.012 (1.3; 715.7) Beta [20]
Recurrent infection 0.110 (11.3; 705.7) Beta [20]
Dead 0.047 (4.9; 712.1) Beta [20]
Discharged vulnerable 2 to:
Remain discharged vulnerable 2 0.846 (22.9; 166.1) Beta [20]
Censored 0.021 (0.6; 188.4) Beta [20]
Recurrent infection 0.126 (3.4; 185.6) Beta [20]
Dead 0.005 (0.1; 188.9) Beta [20]
Recurrent infection to:
Remain recurrent infection 0.671 (19.3; 181.7) Beta [20]
Dead 0.059 (1.71; 199) Beta [20]
Discharged vulnerable 2 0.268 (7.7; 193.3) Beta [20]
Discharged healthy to:
Remain discharged healthy 0.999 (847653; 88) Beta [20]
Dead 0.0001 (9.4; 623113) Beta [20]
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difficulty of gathering health utility estimates from primary
sources. The rate that patients move between compart-
ments in the model was informed by hospital administration
data, obtained from the Western Australian Department of
Health. An absence of individual clinical test results meant
that the classification of illness severity was simplified for
this study. Patients who suffered an infection but did not
require an ICU stay were categorized as having ‘non-severe’
infection, while those who had an infection and a concur-
rent ICU stay were categorized as having ‘severe’ infection.
This assumption may have resulted in an overestimation of
severe cases, however, some simplification was required
based on data availability. The probability of dying from
infection was estimated using the detailed cause of death
data recorded in the Western Australian administrative
dataset. The probability of dying from non-infective health
states was estimated from Australian life tables [14].
Further assumptions relating to the model include an
inability to move between infective categories (e.g. from
‘non-severe’ to ‘severe’) and not accounting for the pos-
sibility of being admitted with a community-acquired
infection (i.e. treating all infections as hospital acquisi-
tions). Such assumptions are necessary and not uncommon,
given data availability or concerns with the accuracy of
certain aspects of collected data. The model used in this
study is flexible and can be updated to incorporate new
evidence if it becomes available.
Results
Reducing patient LOS across the hospital is likely to result in
an improvement in C. difficile-related health outcomes.
Compared to the current environment, each scenario yiel-
ded gains in QALYs and reductions in the total number of C.
difficile infections per annum in Australia. There were also
reductions in the number of patients requiring ICU care,
when each scenario was compared to standard treatment.
The modelled reduction in CDIs per annum in Australia is
in Fig. 1. All scenarios showed a reduction in the average
number of C. difficile infections that could be expected if
LOS-improving scenarios were implemented across
Australia. It is evident that the greatest reduction in in-
fections was experienced when a combination of LOS and
hygiene improvement was implemented, with 2690 in-
fections avoided per year. The worst performing scenario,
reducing LOS by one day but not in conjunction with
another intervention, still reaped significant rewards, with
1102 infections per year avoided compared to usual care.
There were also large gains in the number of QALYs that
could be expected when a LOS scenario was successfully
implemented, compared with usual care. Combining LOS
reduction with a hygiene improvement intervention deliv-
ered the highest QALY gains (37 gained). All scenarios,
including reducing average LOS on its own, by as little as
one day, resulted in an increase in QALYs. These results are
shown in Fig. 2.
Discussion
The results show that C. difficile-related health outcomes
could be significantly improved if the average LOS of all
admitted patients was reduced. These findings are logical,
given the increased risk that an inpatient stay has on
becoming infected and with risk diminishing further if a
well implemented infection control program is running in
parallel.
Given the results of this study, it is realistic to assume
that there are large economic gains to be made by
improving LOS. A reduction in C. difficile infections would
result in a reduction in hospital resource use, reduction in
treatment costs and most significantly, a large reduction in
bed costs. This is particularly the case when CDI-related
ICU admissions are reduced, given the high cost of an ICU
bed. However, calculating the economic gains accurately is
problematic at this stage, given that there has yet to be an
attempt to thoroughly describe and quantify the costs
associated with an intervention that specifically addresses
reducing overall inpatient LOS. Further work in this area
would be an important addition to the evidence base and
likely to be of interest to hospital decision-makers who are
tasked with managing high demand for services with non-
increasing budgets.
Figure 1 Average change in number of C. difficile infections, compared to usual care.
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Translating the results into practice will also be difficult.
There are practical issues with attempting to further
reduce LOS, especially considering clinicians are already
tasked with juggling high occupancy rates and high patient
throughput. Impacting time-to-safe-patient-discharge is
influenced by numerous factors within the healthcare sys-
tem, making its navigation complex and requiring further
strategic consideration. Numerous clinical and administra-
tive processes are required before a patient can be dis-
charged and we hypothesise that speeding the
administrative process is most likely to be where improve-
ments in reducing LOS might be seen. This is noted else-
where in the literature, where improvements in physician
to nurse communication, standardization of discharge
practice for an entire facility and the use of tailored
discharge plans were frequently noted as being processes
that should be scrutinised and maintained to ensure
appropriate and timely discharge is happening in hospitals
[22e24]. The maximum achievable reduction in overall LOS
is likely to be site-specific and varied, due to a number of
locally-appropriate factors. This study hypothesises re-
ductions in average LOS that may be achievable in some
settings and not in others. However, the model is of value
because it can be used to analyse numerous different LOS
scenarios, with the results helping to inform C. difficile-
related decision-making.
It is also worth noting that whilst infection control is a
critical component of the healthcare system, it is an
overarching support rather than a stand-alone aspect of a
hospital. There is no guarantee that cash gains will be
directly noticed by the infection control department,
despite a reduction in infections. What there will be is an
improvement in hospital efficiency, as an intervention that
effectively reduces infection risk will free up beds, allowing
extra capacity to treat patients. The economic benefits of
interventions that reduce C. difficile infections are unlikely
to relate to the financial bottom line for the infection
control department, but downstream effects, such as sav-
ings in other areas of the hospital or contribution to a
reputational gain are plausible.
Conclusion
C. difficile is a problematic infection in the Australian
hospital setting and efforts to reduce its transmission need
to remain a priority for infection control departments. This
study has shown that limiting overall inpatient LOS has the
capacity to disrupt transmission rates, yielding a reduction
in total infections and ICU stays. The results also show that
by reducing average LOS, we could expect to see an in-
crease in QALYs and a reduction in C. difficile-related costs,
although further study is required to formally quantify the
latter. Implementing a LOS-focused intervention would be a
practical challenge but is not unattainable with the right
clinical and decision-maker endorsement of its value.
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